Roche

News

Vabysmo vaults into Roche’s top growth spot

The undisputed star of Roche’s pharma portfolio in the first quarter of this year is eye disease therapy Vabysmo, heading for blockbuster territory after posting sales of

News

Roche’s Polivy gets FDA OK in frontline lymphoma

The FDA has set aside reservations it had about the use of Roche’s Polivy as a first-line treatment with chemotherapy for diffuse large B-cell lymphoma (DLBCL), and cleare

News

Roche launches its decision-making algorithm marketplace

In a further sign of pharma embracing digital technologies, Roche has launched a library of medical algorithms designed to make clinical decision-making faster and more ta

News